The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
复制标题
癌症和心脏代谢疾病中的先天免疫信号:是朋友还是敌人?
DOI:
10.1016/j.canlet.2016.06.004
复制
发表时间:
2017
期刊:
影响因子:
9.7
通讯作者:
Li Hongliang
中科院分区:
文献类型:
--
作者:
Wang Weijun;Zhang Yaxing;Yang Ling;Li Hongliang
The innate immune system is responsible for sensing pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) by several types of germline-encoded pattern-recognition receptors (PRRs). It has the capacity to help the human body maintain homeostasis under normal conditions. However, in pathological conditions, PAMPs or DAMPs trigger aberrant innate immune and inflammatory responses and thus negatively or positively influence the progression of cancer and cardiometabolic diseases. Interestingly, we found that some elements of innate immune signaling are involved in these diseases partiallyviaimmune-independent manners, indicating a deeper understanding of the function of innate immune signaling in these diseases is urgent. In this review, we summarize the primary innate immune signaling pathways and their association with cancer and cardiometabolic diseases, with the aim of providing effective therapies for these diseases.